Error in Table 3
In the original publication [1], there was a mistake in Table 3. ELISA analysis of protein and antigen concentrations of different inactivated virus samples as published. In the table, data in the second column (protein concentration) and the third column (antigen concentration) are raw data, and data in the fourth column were calculated from data in the third column divided by data in the second column. In the original publication, data in the fourth column were wrongly entered in. The corrected Table 3 appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Text Correction
With regard to the correction of Table 3, a correction has been made to *4. Discussion, Paragraph 4*:
**The results showed that formaldehyde treatment reduced the homogeneity of virus particles. Although there were no significant differences in the negative staining or circular dichroism spectra, the treament’s performance in terms of size exclusion chromatography became worse, and its UV absorption curve became less sharp. An examination of the S protein showed that the viral S protein after formaldehyde treatment displayed dispersive bands and cross-linking upon SDS-PAGE. Compared with the 20–24 h BPL treatment, the S antigen content decreased by more than twice. After BPL treatment, the virus particles remained relatively homogenous, and the S protein was still clear. These results confirm the chemical properties of formaldehyde, which can cause viral protein cross-linking and denaturation and damage viral surface antigens. Therefore, although formaldehyde does not destroy the morphology or secondary structure of the virus, compared with BPL, formaldehyde is not a suitable SARS-CoV-2 inactivator.**
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
ELISA analysis of protein and antigen concentrations of different inactivated virus samples.
Sample | Protein Concentration (μg/mL) | Antigen Concentration (U/mL) | Ratio |
---|---|---|---|
Formaldehyde-inactivated | 332.4 | 267.9 | 0.81 |
Formaldehyde + BPL-inactivated | 211.33 | 224.57 | 1.06 |
BPL-inactivated | 327.56 | 623.38 | 1.90 |
BPL + BPL-inactivated | 308.19 | 372.56 | 1.21 |
Reference
1. Yu, S.; Wei, Y.; Liang, H.; Ji, W.; Chang, Z.; Xie, S.; Wang, Y.; Li, W.; Liu, Y.; Wu, H. et al. Comparison of Physical and Biochemical Characterizations of SARS-CoV-2 Inactivated by Different Treatments. Viruses; 2022; 14, 1938. [DOI: https://dx.doi.org/10.3390/v14091938] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/36146745]
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Details

1 Beijing Institute of Biological Products Company Limited, Beijing 100176, China;
2 China National Biotec Group Company Limited, Beijing 100024, China